NMR studies of the C-terminus of alpha4 reveal possible mechanism of its interaction with MID1 and protein phosphatase 2A

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Du, Haijuan ^a   Massiah, Michael A ^a  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA4 PROTEIN; BINDING PROTEIN; CARRIER PROTEINS AND BINDING PROTEINS; DODECYL SULFATE SODIUM; MICROTUBULE ASSOCIATED PROTEIN; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN BBOX1; PROTEIN MID1; UNCLASSIFIED DRUG; IGBP1 PROTEIN, HUMAN; MICROTUBULE PROTEIN; PHOSPHOPROTEIN PHOSPHATASE 2; SIGNAL PEPTIDE;

ALPHA HELIX; AQUEOUS SOLUTION; ARTICLE; BINDING AFFINITY; BINDING SITE; COMPLEX FORMATION; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; HUMAN; IMAGE ANALYSIS; MICELLE; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN SECONDARY STRUCTURE; PROTON NUCLEAR MAGNETIC RESONANCE; SURFACE PROPERTY; AMINO ACID SEQUENCE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECT; METABOLISM; MOLECULAR GENETICS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTEIN TERTIARY STRUCTURE; SOLUTION AND SOLUBILITY; STATIC ELECTRICITY;

AMINO ACID SEQUENCE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MAGNETIC RESONANCE SPECTROSCOPY; MICELLES; MICROTUBULE PROTEINS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN PHOSPHATASE 2; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; SODIUM DODECYL SULFATE; SOLUTIONS; STATIC ELECTRICITY;

EID: 83355170623     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028877     Document Type: Article

References (60)

1. Chuang E, Fisher TS, Morgan RW, Robbins MD, Duerr JM, et al. (2000) The CD28 and CTLA-4 receptors associate with the serine/threonine phosphatase PP2A. Immunity 13: 313-322.
2. Inui S, Kuwahara K, Mizutani J, Maeda K, Kawai T, et al. (1995) Molecular cloning of a cDNA clone encoding a phosphoprotein component related to the Ig receptor-mediated signal transduction. J Immunol 154: 2714-2723.
3. Murata K, Wu J, Brautigan DL, (1997) B cell receptor-associated protein alpha-4 displays rapamycin-sensitive binding directly to the catalytic subunit of protein phosphatase 2A. Proc Natl Acad Sci U S A 94: 10624-10629.
4. Inui S, Sanjo H, Maeda K, Yamamoto H, Miyamoto E, et al. (1998) Ig receptor binding protein 1 (alpha4) is associated with a rapamycin-sensitive signal transduction in lymphocytes through direct binding to the catalytic subunit of protein phosphatase 2A. Blood 92: 539-546.
5. Onda M, Inui S, Maeda K, Suzuki M, Takahashi E, et al. (1997) Expression and chromosomal localization of the human alpha 4/IGBP1 gene, the structure of which is closely related to the yeast TAP42 protein of the rapamycin-sensitive signal transduction pathway. Genomics 46: 373-378.
6. Cygnar KD, Gao X, Pan D, Neufeld TP, (2005) The phosphatase subunit tap42 functions independently of target of rapamycin to regulate cell division and survival in Drosophila. Genetics 170: 733-740.
7. Jiang Y, Broach JR, (1999) Tor proteins and protein phosphatase 2A reciprocally regulate Tap42 in controlling cell growth in yeast. Embo J 18: 2782-2792.
8. Dutcher JP, (2004) Mammalian target of rapamycin (mTOR) Inhibitors. Curr Oncol Rep 6: 111-115.
9. Mita MM, Mita A, Rowinsky EK, (2003) Mammalian target of rapamycin: a new molecular target for breast cancer. Clin Breast Cancer 4: 126-137.
10. Rao RD, Buckner JC, Sarkaria JN, (2004) Mammalian target of rapamycin (mTOR) inhibitors as anti-cancer agents. Curr Cancer Drug Targets 4: 621-635.
11. Smetana JH, Oliveira CL, Jablonka W, Aguiar Pertinhez T, Carneiro FR, et al. (2006) Low resolution structure of the human alpha4 protein (IgBP1) and studies on the stability of alpha4 and of its yeast ortholog Tap42. Biochim Biophys Acta 1764: 724-734.
12. Sontag E, (2001) Protein phosphatase 2A: the Trogan Horse of cellular signaling. Cellular Signalling 13: 7-11.
13. Turowski P, Favre B, Campbell KS, Lamb NJ, Hemmings BA, (1997) Modulation of the enzymatic properties of protein phosphatase 2A catalytic subunit by the recombinant 65-kDa regulatory subunit PR65alpha. Eur J Biochem 248: 200-208.
14. Kremmer E, Ohst K, Kiefer J, Brewis N, Walter G, (1997) Separation of PP2A core enzyme and holoenzyme with monoclonal antibodies against the regulatory A subunit: abundant expression of both forms in cells. Mol Cell Biol 17: 1692-1701.
15. Mayer-Jaekel RE, Hemmings BA, (1994) Protein phosphatase 2A-a 'menage a trois'. Trends Cell Biol 4: 287-291.
16. Han X, Du H, Massiah MA, (2011) Detection and characterization of the in vitro e3 ligase activity of the human MID1 protein. Journal of Molecular Biology 407: 505-520.
17. Trockenbacher A, Suckow V, Foerster J, Winter J, Krauss S, et al. (2001) MID1, mutated in Opitz syndrome, encodes an ubiquitin ligase that targets phosphatase 2A for degradation. Nat Genet 29: 287-294.
18. Liu J, Prickett TD, Elliott E, Meroni G, Brautigan DL, (2001) Phosphorylation and microtubule association of the Opitz syndrome protein mid-1 is regulated by protein phosphatase 2A via binding to the regulatory subunit alpha 4. Proc Natl Acad Sci U S A 98: 6650-6655.
19. Schweiger S, Foerster J, Lehmann T, Suckow V, Muller YA, et al. (1999) The Opitz syndrome gene product, MID1, associates with microtubules. Proc Natl Acad Sci U S A 96: 2794-2799.
20. Short KM, Cox TC, (2006) Sub-classification of the rbcc/trim superfamily reveals a novel motif necessary for microtubule binding. J Biol Chem.
21. Cox T, (2004) Taking it to the max: The genetic and developmental mechanisms coordinating midfacial morphogenesis and dysmorphology. Clin Genet 65: 163-176.
22. Gaudenz K, Roessler E, Quaderi N, Franco B, Feldman G, et al. (1998) Opitz G/BBB syndrome in Xp22: mutations in the MID1 gene cluster in the carboxy-terminal domain. Am J Hum Genet 63: 703-710.
23. Granata A, Quaderi NA, (2003) The Opitz syndrome gene MID1 is essential for establishing asymmetric gene expression in Hensen's node. Dev Biol 258: 397-405.
24. Quaderi NA, Schweiger S, Gaudenz K, Franco B, Rugarli EI, et al. (1997) Opitz G/BBB syndrome, a defect of midline development, is due to mutations in a new RING finger gene on Xp22. Nat Genet 17: 285-291.
25. Schweiger S, Schneider R, (2003) The MID1/PP2A complex: a key to the pathogenesis of Opitz BBB/G syndrome. Bioessays 25: 356-366.
26. Cox TC, Allen LR, Cox LL, Hopwood B, Goodwin B, et al. (2000) New mutations in MID1 provide support for loss of function as the cause of X-linked Opitz syndrome. Hum Mol Genet 9: 2553-2562.
27. Short KM, Hopwood B, Yi Z, Cox TC, (2002) Mid1 and Mid2 homo- and heterodimerise to tether the rapamycin-sensitive PP2A regulatory subunit, Alpha 4, to microtubules: implications for the clinical variability of X-linked Opitz GBBB syndrome and other developmental disorders. BMC Cell Biology 3: 1-14.
28. Everett AD, Brautigan DL, (2002) Developmental Expresssion of alpha4 protein phosphase regulatory subunit in tissues affected by Opitz syndrome. Developmental Dynamics 224: 461-464.
29. De Falco F, Cainarca S, Andolfi G, Ferrentino R, Berti C, et al. (2003) X-linked Opitz syndrome: novel mutations in the MID1 gene and redefinition of the clinical spectrum. Am J Med Genet A 120A: 222-228.
30. Graham JM Jr, Wheeler P, Tackels-Horne D, Lin AE, Hall BD, et al. (2003) A new X-linked syndrome with agenesis of the corpus callosum, mental retardation, coloboma, micrognathia, and a mutation in the Alpha 4 gene at Xq13. Am J Med Genet A 123A: 37-44.
31. LeNoue-Newton M, Watkins GR, Zou P, Germane KL, McCorvey LR, et al. (2011) The E3 ubiquitin ligase- and protein phosphatase 2A (PP2A)-binding domains of the Alpha4 protein are both required for Alpha4 to inhibit PP2A degradation. The Journal of biological chemistry 286: 17665-17671.
32. Yang J, Roe SM, Prickett TD, Brautigan DL, Barford D, (2007) The structure of Tap42/alpha4 reveals a tetratricopeptide repeat-like fold and provides insights into PP2A regulation. Biochemistry 46: 8807-8815.
33. Smetana JHC, Oliveira CLP, Jablonka W, Pertinhez TA, Carneiro FRG, et al. (2006) Low Resolution Structure of the Human alpha4 protein (IgBP1) and studies on the stability of alpha4 and its yeast ortholog Tap42. Biochim Biophys Acta 1764: 724-734.
34. Aranda-Orgilles B, Trockenbacher A, Winter J, Aigner J, Kohler A, et al. (2008) The Opitz syndrome gene product MID1 assembles a microtubule-associated ribonucleoprotein complex. Hum Genet 123: 163-176.
35. Delaglio F, Grzesiek S, Vuister GW, Zhu G, Pfeifer J, et al. (1995) NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR 6: 277-293.
36. Goddard TD, Kneller DG, SPARKY 3. University of Californa, San Fancisco.
37. Cornilescu G, Delaglio F, Bax A, (1999) Protein backbone angle restraints from searching a database for chemical shift and sequence homology. J Biomol NMR 13: 289-302.
38. Guntert P, (2004) Automated NMR structure calculation with CYANA. Methods Mol Biol 278: 353-378.
39. Laskowski RA, MacArthur MW, Moss DS, Thornton JM, (1993) PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Cryst 26: 283-291.
40. Massiah MA, Simmons BN, Short KM, Cox TC, (2006) Solution structure of the RBCC/TRIM B-box1 domain of human MID1: B-box with a RING. J Mol Biol 358: 532-545.
41. Wishart DS, Sykes BD, (1994) The 13C chemical-shift index: a simple method for the identification of protein secondary structure using the 13C chemical-shift data. J Biomol NMR 222: 311-333.
42. Andersen NH, Cao B, Chen C, (1992) Peptide/protein structure analysis using the chemical shift index method: upfield alpha-CH values reveal dynamic helices and alpha L sites. Biochemical and biophysical research communications 184: 1008-1014.
43. Wishart DS, Sykes BD, Richards FM, (1992) The chemical shift index: a fast and simple method for the assignment of protein secondary structure through NMR spectroscopy. Biochemistry 31: 1647-1651.
44. Lee MS, Palmer AG, Wright PE, (1992) Relationship between 1H and 13C NMR chemcial shifts and the secondary and tertiary structure of a zinc finger peptide. J Biomol NMR 2: 307-322.
45. Schwarzinger S, Kroon GJA, Foss TR, Wright PE, Dyson HJ, (2000) Random coil chemical shifts in acidic 8 M urea: implementation of random coil shift data in NMRView. J Biomol NMR 18: 43-48.
46. Parker W, Song PS, (1992) Protein structures in SDS micelle-protein complexes. Biophys J 61: 1435-1439.
47. Bystrom R, Aisenbrey C, Borowik T, Bokvist M, Lindstrom F, et al. (2008) Disordered proteins: biological membranes as two-dimensional aggregation matrices. Cell Biochem Biophys 52: 175-189.
48. Hiller S, Garces RG, Malia TJ, Orekhov VY, Colombini M, et al. (2008) Solution structure of the integral human membrane protein VDAC-1 in detergent micelles. Science 321: 1206-1210.
49. Dunker AK, Oldfield CJ, Meng J, Romero P, Yang JY, et al. (2008) The unfoldomics decade: an update on intrinsically disordered proteins. BMC Genomics 9 (Suppl 2): S1.
50. Galea CA, Nourse A, Wang Y, Sivakolundu SG, Heller WT, et al. (2008) Role of intrinsic flexibility in signal transduction mediated by the cell cycle regulator, p27 Kip1. J Mol Biol 376: 827-838.
51. Galea CA, Wang Y, Sivakolundu SG, Kriwacki RW, (2008) Regulation of cell division by intrinsically unstructured proteins: intrinsic flexibility, modularity, and signaling conduits. Biochemistry 47: 7598-7609.
52. Dancheck B, Nairn AC, Peti W, (2008) Detailed Structural Characterization of Unbound Protein Phosphatase 1 Inhibitors. Biochemistry.
53. Xu Y, Chen Y, Zhang P, Jeffrey PD, Shi Y, (2008) Structure of a protein phosphatase 2A holoenzyme: insights into B55-mediated Tau dephosphorylation. Molecular cell 31: 873-885.
54. Yang J, Roe SM, Prickett TD, Brautigan DL, Barford D, (2007) The Structure of Tap42/alpha4 Reveals a Tetratricopeptide Repeat-like Fold and Provides Insights into PP2A Regulation. Biochemistry 46: 8807-8815.
55. Prickett TD, Brautigan DL, (2004) Overlapping binding sites in protein phosphatase 2A for association with regulatory A and alpha-4 (mTap42) subunits. J Biol Chem 279: 38912-38920.
56. Groves MR, Hanlon N, Turowski P, Hemmings BA, Barford D, (1999) The structure of the protein phosphatase 2A PR65/A subunit reveals the conformation of its 15 tandemly repeated HEAT motifs. Cell 96: 99-110.
57. Trockenbacher A, Suckow V, Foerster J, Winter J, Krauss S, et al. (2001) MID1, mutated in Opitz syndrome, encodes an ubiquitin ligase that targets phosphatase 2A for degradation. Nat Genet 29: 287-294.
58. Tao H, Simmons BN, Singireddy S, Jakkidi M, Short KM, et al. (2008) Structure of the MID1 tandem B-boxes reveals an interaction reminiscent of intermolecular ring heterodimers. Biochemistry 47: 2450-2457.
59. Jo S, Vargyas M, Vasko-Szedlar J, Roux B, Im W, (2008) PBEQ-Solver for online visualization of electrostatic potential of biomolecules. Nucleic acids research 36: W270-275.
60. Im W, Beglov D, Roux B, (1998) Continuum Solvation Model: Computation of Electrostatic Forces from Numerical Solutions to the Poisson-Boltzmann Equation. Computer Physics Communications 111: 59-75.